Month: March 2014

One of the latest fads people are trying is a gluten free diet to lose weight. … if you can tolerate gluten you should focus on developing a healthy diet overall. … of the low-nutrient, high-calorie foods that a gluten-free diet eliminates.

(Reuters) – Sterigenics, a sterilization services provider owned by private equity firm GTCR LLC, has reached a deal to buy Canadian medical isotopes supplier Nordion Inc for $727 million. The offer of $11.75 per share represents a 12 percent premium to Nordion’s closing price on the New York Stock Exchange on Thursday, the companies said. “That’s basically what our fair value was (for Nordion), so we think they’re getting a fair price,” Morningstar analyst David Krempa said. Nordion’s U.S.-listed stock trades at 8.3 times forward earnings, a slight discount to the sector median of 11.4.

The Louisiana Department of Corrections does not plan to appeal a U.S. Court decision this week that compels it to reveal to inmates on death row the content and maker of drugs used in lethal injections, a prisons official said on Friday. The decision by the U.S. Court of Appeals for the Fifth Circuit on Thursday was one in a series in favor of inmates who have sought delays for their execution while they seek information about the contents of lethal injection cocktails and clarity on who would be supplying the drugs. The decisions are likely to delay executions across the country as lawyers for inmates in other states launch similar efforts on their behalf in states looking to develop new means of lethal injection after supplies of drugs they have once used have run dry. “The state will not appeal the decision,” Darryl Campbell, the executive management officer of the Louisiana Department of Corrections, told Reuters.

ALBANY, N.Y. (AP) — About one-third of professional mixed martial arts matches end in knockout or technical knockout, indicating a higher incidence of brain trauma than boxing or other martial arts, according to a new study in the American Journal of Sports Medicine.

Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday. Hemophilia B is a rare, inherited disorder in which a person’s blood does not clot properly, which can lead to prolonged bleeding and bruising. Biogen is developing the drug in partnership with Swedish Orphan Biovitrum AB. Patients with hemophilia A lack or have reduced levels of coagulation factor VIII.

By Shereen Jegtvig NEW YORK (Reuters Health) – Adults hospitalized with mild head injuries have almost double the risk of dying in the next 15 years compared to similar people with no history of head injury, according to a new UK study. It’s not clear whether lifestyle before and after a head injury is to blame for the increased risk, if the injury itself has lingering effects, or both, researchers say. “There is evidence in the study that points to lifestyle factors and health before and after the head injury,” said lead author Tom McMillan, of the Institute of Health and Wellbeing at the University of Glasgow. High rates of death in the year following a severe head injury have been well documented, McMillan and his colleagues write in the Journal of Neurology, Neurosurgery and Psychiatry.

By Lawrence Hurley WASHINGTON (Reuters) – A U.S. judge on Friday threw out a federal regulation that allowed government agencies to transfer water between different water bodies, such as rivers and lakes, without needing to safeguard for pollution. U.S. District Judge Kenneth Karas of the Southern District of New York ordered the U.S. Environmental Protection Agency (EPA) to go back to the drawing board on one aspect of the 2008 regulation. The regulation, known as the water transfers rule, exempts transfers from the national water discharge permit program that is administered by the EPA.

AUSTIN, Texas (AP) — Political opposition in Texas to the federal health care overhaul hasn’t helped enrollment numbers that lag behind expectations as next week’s deadline to sign up looms, Health and Human Services Secretary Kathleen Sebelius said Friday.